Home
Cancer Genetics, Inc.

Cancer Genetics, Inc. Market Share Analysis for June 2026

Health > Biotechnology and Pharmaceuticals

Domaincancergenetics.com

Year Founded1999

Employees51 - 200

Annual Revenue--

Cancer Genetics, Inc.

Cancer Genetics, Inc. (including company regionals)

cancergenetics.com

See more website traffic and engagement information

Cancer Genetics, Inc. Revenue up to June 2026 is --

revenue generated by Cancer Genetics, Inc. top domains

Cancer Genetics, Inc. top domains revenue over 3 years

Revenue for Cancer Genetics, Inc. top domains

cancergenetics.com--

See more with Sales Intelligence

Total visits to Cancer Genetics, Inc.'s top domains

Understand Cancer Genetics, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Cancer Genetics, Inc.'s top domains

Analyze Cancer Genetics, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Cancer Genetics, Inc.'s top domains

See how Cancer Genetics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Cancer Genetics, Inc. top competitors by domain

Top similar sites in June 2026, ranked by their affinity

acaciapharma.comCompany NameAcacia PharmaEmployees51 - 200HQUnited Kingdom, CambridgeAnnual revenue< $1MTotal visits1.1KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Cancer Genetics, Inc.

These are the website technologies, by industry, used by Cancer Genetics, Inc. top domains

Payment & Currencies (7)

Cart Functionality

Social (5)

Facebook Connect

Widget (5)

Twemoji

Advertising (4)

AppNexus

More Technologies

10

See all

News & Signals from Cancer Genetics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCancer Genetics, Inc. partners with Novellusdx.For instance, cancer Genetics announced merger with NovellusDx as a result of which Cancer Genetics portfolio of oncology test and services will combine with next-generation sequencing and other technologies of NovellusDx.

NewsCancer Genetics, Inc. launched proof-of-concept program on Sep 3rd '20.Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, and StemoniX, Inc., a company empowering the discovery of new medicines through the convergence of novel human biology and software technologies, today announced a joint proof-of-concept program.

NewsCancer Genetics, Inc. merged with Stemonix on Sep 19th '20.Halper Sadeh LLP, a global investor rights law firm, is investigating whether Cancer Genetics, Inc. (NASDAQ: CGIX ) and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with Cancer Genetics's proposed merger with StemoniX, Inc.